See All Slides - tctmd.com

Slides

Presentation TCT 2014

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Presenter: John S. Douglas Jr, Sherif F. Nagueh, Howard C. Herrmann, Rod H. Stables

September 16, 2014

Presentation TCT 2014

Experimental Requirements and Device Validation: Critical Changes Impacting Transition to Human Testing

Presenter: Alexandre Abizaid, Elazer R. Edelman, Greg L. Kaluza

September 16, 2014

Presentation TCT 2014

A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Martin B. Leon

September 16, 2014

Presentation TCT 2014

Improving STEMI Processes of Care, Choosing the Right Metrics, and Assessing Outcomes: Is It All About Door-to Balloon Time?

Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Alice K. Jacobs

September 16, 2014

Presentation TCT 2014

Special Lecture: What Have I Learned from Treating Left Main Bifurcation Lesions in the Last 20 Years?

Presenter: Jean Fajadet, Marie-Claude Morice, Margaret B. McEntegart, Seung-Jung Park

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

Atherosclerosis and Vascular Disease Over the Millennia: Whats the Connection with AAA Disease?

Presenter: Frank J. Criado, Christopher K. Zarins, Robert A. Lookstein

September 16, 2014

Presentation TCT 2014

Clinical Indications for TAVR: Where are We and Where are We Going?

Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, A. Pieter Kappetein

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

TEE Assessment Before, During, and After LAA Closure

Presenter: Ted E. Feldman, Saibal Kar, Zoltan G. Turi, Bushra S Rana

September 16, 2014

Advertisement

Slides

Diagnostic Evaluation of Patients Referred with HCM Diagnosis

Experimental Requirements and Device Validation: Critical Changes Impacting Transition to Human Testing

A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions

Improving STEMI Processes of Care, Choosing the Right Metrics, and Assessing Outcomes: Is It All About Door-to Balloon Time?

Special Lecture: What Have I Learned from Treating Left Main Bifurcation Lesions in the Last 20 Years?

Scaffolds vs Stents: Biomechanics and Vascular Responses

Atherosclerosis and Vascular Disease Over the Millennia: Whats the Connection with AAA Disease?

Clinical Indications for TAVR: Where are We and Where are We Going?

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

TEE Assessment Before, During, and After LAA Closure

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content